Literature DB >> 15148104

Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.

Kathleen J Smith1, Elizabeth Jacobson, Sate Hamza, Henry Skelton.   

Abstract

BACKGROUND: Idiopathic hypereosinophilic syndrome (HES) is a diagnosis made after the exclusion of other causes of eosinophilia. However, differentiation of idiopathic HES from eosinophilic leukemia is sometimes difficult. In some cases, these diagnoses can be differentiated by cytogenetic or molecular findings, as illustrated in the patients described herein. OBSERVATIONS: We describe 3 patients with HES and associated pruritus; 1 patient also had recurrent lesions of eosinophilic cellulitis. All 3 patients were initially diagnosed as having idiopathic HES, but after evaluation and demonstration of molecular abnormalities, they were classified as having eosinophilic leukemia.
CONCLUSIONS: Patients with a diagnosis of idiopathic HES should be evaluated for cytogenetic or molecular genetic abnormalities. These abnormalities can establish a diagnosis of chronic eosinophilic leukemia and may provide clues for emerging therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148104     DOI: 10.1001/archderm.140.5.584

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

1.  Chronic eosinophilic leukemia with the FIP1L1-PDGFRalpha fusion gene in a patient with a history of combination chemotherapy.

Authors:  Yasuhiro Tanaka; Masayuki Kurata; Katsuhiro Togami; Haruyuki Fujita; Naoko Watanabe; Akiko Matsushita; Akinori Maeda; Kenichi Nagai; Akiko Sada; Toshimitsu Matsui; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

2.  Current concepts on the pathogenesis of the hypereosinophilic syndrome/chronic eosinophilic leukemia.

Authors:  Yoshiyuki Yamada; Marc E Rothenberg; Jose A Cancelas
Journal:  Transl Oncogenomics       Date:  2006-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.